Doxycycline and Novolog flexpen drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported only by a few people who take Doxycycline and Novolog flexpen together.
The phase IV clinical study analyzes what interactions people who take Doxycycline and Novolog flexpen have. It is created by eHealthMe based on reports of 3 people who take the same drugs from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
3 people who take Doxycycline and Novolog flexpen together, and have interactions are studied.
What is Doxycycline?
Doxycycline has active ingredients of doxycycline hyclate. It is often used in acne. eHealthMe is studying from 56,940 Doxycycline users for its effectiveness, alternative drugs and more.
What is Novolog flexpen?
Novolog flexpen has active ingredients of insulin aspart recombinant. It is often used in diabetes. eHealthMe is studying from 320 Novolog flexpen users for its effectiveness, alternative drugs and more.
Number of Doxycycline and Novolog flexpen reports submitted per year:
Common Doxycycline and Novolog Flexpen drug interactions by gender *:
female:
- Death
male:
- Drug ineffective
- Myocardial infarction
Common Doxycycline and Novolog Flexpen drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Death
- Drug ineffective
- Myocardial infarction
* Approximation only. Some reports may have incomplete information.
Do you take Doxycycline and Novolog flexpen?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
- Doxycycline (56,940 reports)
- Novolog flexpen (320 reports)
Browse all drug interactions of Doxycycline and Novolog flexpen:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Doxycycline side effects:
- Pain: 3,612 reports
- Rashes (redness): 3,569 reports
- Fatigue (feeling of tiredness): 3,515 reports
- Diarrhea: 3,155 reports
- Breathing difficulty: 3,076 reports
- Headache (pain in head): 2,941 reports
Browse all side effects of Doxycycline:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Doxycycline interactions:
- Doxycycline and Prednisone: 6,963 reports
- Doxycycline and Omeprazole: 5,953 reports
- Doxycycline and Aspirin: 5,812 reports
- Doxycycline and Gabapentin: 4,890 reports
- Doxycycline and Furosemide: 4,663 reports
- Doxycycline and Lisinopril: 4,458 reports
- Doxycycline and Amoxicillin: 3,885 reports
- Doxycycline and Nexium: 3,719 reports
- Doxycycline and Tramadol: 3,682 reports
- Doxycycline and Vitamin d: 3,592 reports
Browse all interactions between Doxycycline and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on doxycycline hyclate and insulin aspart recombinant (the active ingredients of Doxycycline and Novolog flexpen, respectively), and Doxycycline and Novolog flexpen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Doxycycline and Novolog flexpen.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Pentam and Conjunctivitis Exacerbated - 5 seconds ago
- Creon and Headache - 12 seconds ago
- Xarelto and Haematuria - 22 seconds ago
- Corgard vs. Aspirin And Dipyridamole - 26 seconds ago
- Beyaz vs. Loestrin 24 Fe - 27 seconds ago
- Xarelto and Fall - 41 seconds ago
- Augmentin and Restoril drug interaction - 49 seconds ago
- Xarelto and Upper Gastrointestinal Haemorrhage - a minute ago
- Fosamax and Sulfamethoxazole drug interaction - a minute ago
- Enalapril Maleate vs. Plendil - a minute ago